PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-16.12%
Both yoy net incomes decline, with MRVL at -26.69%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-10.84%
Negative yoy D&A while MRVL is 1.70%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
9.76%
Deferred tax of 9.76% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
-162.36%
Both reduce yoy usage, with MRVL at -60.05%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-97.00%
Both reduce yoy inventory, with MRVL at -9.49%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-196.37%
Both reduce yoy usage, with MRVL at -118.56%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-96.08%
Both negative yoy, with MRVL at -100.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-59.92%
Both yoy CFO lines are negative, with MRVL at -30.65%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-31.28%
Negative yoy CapEx while MRVL is 89.33%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-24.62%
Both yoy lines negative, with MRVL at -123.53%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
34.53%
At 75-90% of MRVL's 42.31%. Bill Ackman would push for additional sales if those assets are non-strategic or have peaked in value.
625.00%
Growth well above MRVL's 91.81%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
727.78%
Investing outflow well above MRVL's 68.30%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-25.00%
Negative yoy issuance while MRVL is 29.53%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-303.51%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.